Schedule 13G ownership disclosure
Oncobiologics, Inc.
Security class unavailable · CUSIP: 68235M105
Event date: 2018-10-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001341004-18-000596
- Form type
- SC 13G
- Filer
- Outlook Therapeutics, Inc.
- CIK
- CIK 1649989
- Filed
- Oct 26, 2018
- Reporting period
- Oct 26, 2018
- Description
- Schedule 13G beneficial ownership